2024 annual financial data
Eton Pharmaceuticals 2024 Operating margin
Direct answer
Operating margin was -6.66%.
Operating income was -2,597,000 USD and net income was -3,823,000 USD.
Operating cash flow was 969,000 USD.
Get free Eton Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 39,011,000 USD
- Operating income
- -2,597,000 USD
- Net income
- -3,823,000 USD
- Operating cash flow
- 969,000 USD